GlaxoSmithKline annual profits boosted by US arm
600885
GlaxoSmithKline, Europe's biggest drug maker, has booked a 14.9-percent increase in net profits for 2006, buoyed by soaring sales in the United States and despite a poor performance in Europe.
511128
GlaxoSmithKline sees profits for 2004 fall 9%, but Europe's biggest drugmaker says a recovery during 2005 is on the way.
224792
Abbott Laboratories, the maker of health-care products ranging from pediatric nutritional drinks to HIV tests, said third-quarter profit rose 15 percent as prescriptions climbed for its Humira rheumatoid-arthritis drug.
562473
The drugmaker announces another great quarter of growth.
138104
Human Genome Sciences could see more than $180 million from a new deal with drug maker GlaxoSmithKline. Glaxo has acquired exclusive rights to an experimental drug called Albugon, which Human Genome Sciences
29655
GlaxoSmithKline Plc will pay a net $3.1   billion to settle an ongoing tax dispute with the U.S.   government, which was to go to trial next year, Europe's   biggest drugmaker said on Monday.
557027
Drug maker GlaxoSmithKline, which has co-US headquarters in Philadelphia and Research Triangle Park, has acquired exclusive rights to a potential diabetes treatment in a deal that could be worth more than $180 million.
419348
Merck & Co  reported a better-than-expected profit on Monday, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.
690923
Walgreen Co. (WAG.N: Quote, Profile, Research) , the top US drugstore chain, on Monday said quarterly profit rose 18.1 percent due to rising prescription demand and strong sales from its
261103
Drugs giant GlaxoSmithKline agrees to pay out a record $3.1bn to end a tax row with the US government.
596613
Sanofi-Aventis SA, the world&#39;s third- largest drugmaker, said predecessor company Sanofi-Synthelabo SA&#39;s first-half profit rose 21 percent, helped by demand for the blood thinner Plavix and the cancer treatment Eloxatin.
170831
GlaxoSmithKline Plc  has bought  global rights to Danish biotech company Genmab's  most  promising new drug, a treatment for leukemia, in a record deal  worth up to $2.1 billion, the two firms said on Tuesday.
235034
BASEL, Switzerland  - Net profit at Roche Holding AG  rose 34 percent to 9.17 billion Swiss francs ($7.33 billion) in 2006 due to strong sales of cancer treatments Herceptin and Avastin, just ahead of analysts' expectations.
690168
LONDON -- GlaxoSmithKline PLC, the world's second-largest pharmaceutical company, said Monday that it expects to introduce five new cancer treatments through 2010.
594500
Schering-Plough Corp. SGP.N on  Thursday reported a quarterly profit after a year-ago loss, as  positive foreign exchange trends helped offset poor sales of  its allergy and hepatitis drugs.
510118
Sanofi-Aventis  posted higher-than-expected fourth-quarter current operating profit, despite healthcare savings in Europe as well as generic rivalry, and the drugmaker predicted more growth for 2007.